Zevra Therapeutics, Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Zevra Therapeutics, Inc. stock issued during period, value, new issues for the quarter ending 2024-09-30 was $64.52M.
- Zevra Therapeutics, Inc. stock issued during period, value, new issues for the quarter ending 2021-09-30 was $1.10M.
- Zevra Therapeutics, Inc. stock issued during period, value, new issues for the quarter ending 2019-09-30 was $1.50M, a 78.95% increase year-over-year.
- Zevra Therapeutics, Inc. stock issued during period, value, new issues for the quarter ending 2019-06-30 was $1.23M, a 2.93% increase year-over-year.
- Zevra Therapeutics, Inc. stock issued during period, value, new issues for fiscal 2023 was $6.11M.
- Zevra Therapeutics, Inc. stock issued during period, value, new issues for fiscal 2015 was $59.89M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2024-09-30 | $64.52M 10-Q · filed 2024-11-13 | |
| 2023-12-31 | $6.11M 10-K · filed 2025-03-12 | |
| 2021-09-30 | $1.10M 10-Q · filed 2022-11-10 | |
| 2019-09-30 | $1.50M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $1.23M 10-Q · filed 2019-11-14 | |
| 2019-03-31 | $2.72M 10-Q · filed 2019-11-14 | |
| 2018-09-30 | $836.00K 10-Q · filed 2019-11-14 | |
| 2018-06-30 | $1.19M 10-Q · filed 2019-11-14 | |
| 2018-03-31 | $2.80M 10-Q · filed 2019-11-14 | |
| 2015-12-31 | $59.89M 10-K · filed 2018-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |